Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • KERYX BIOPHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 15.44 M 62.10 M 112.40 M 86.45 M 49.73 M
    Net Receivables 25,000.00 283,000.00 2.57 M 3.54 M 766,000.00
    Total Inventories 0.00 0.00 0.00 0.00 0.00
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses
    Other Current Assets 508,000.00 1.33 M 0.00 0.00 0.00
    Current Assets Total 15.98 M 63.72 M 114.97 M 89.98 M 50.50 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 7.25 M 2.62 M 13.01 M 13.95 M 59,000.00
    Property, Plant & Equipment Net 182,000.00 11.50 M 8.49 M 1.00 M 145,000.00
    Property, Plant & Equipment Gross 771,000.00 11.98 M 8.84 M 1.22 M 262,000.00
    Accumulated Depreciation 589,000.00 488,000.00 356,000.00 217,000.00 117,000.00
    Other Assets 3.23 M 3.23 M 3.84 M 160,000.00 158,000.00
    Deferred Charges 0.00 0.00 0.00 49,000.00 26,000.00
    Tangible Other Assets 0.00 0.00 0.00 67,000.00 0.00
    Intangible Other Assets 3.23 M 3.23 M 3.84 M 44,000.00 132,000.00
    Total Assets 26.63 M 81.06 M 140.31 M 105.10 M 50.86 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 0.00 0.00 0.00 0.00
    Accrued Payroll 496,000.00 1.25 M 1.53 M 936,000.00 743,000.00
    Income Taxes Payable 0.00 0.00 0.00 0.00 0.00
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 1.58 M 1.02 M 200,000.00 103,000.00 140,000.00
    Current Liabilities Total 6.69 M 21.41 M 12.19 M 6.09 M 3.96 M
    Long Term Debt 0.00 0.00 0.00 0.00 0.00
    Provision for Risks & Charges 188,000.00
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 17.31 M 11.02 M 0.00 0.00 0.00
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 4.12 M 4.21 M 4.30 M 4.33 M 4.10 M
    Total Liabilities 28.12 M 36.64 M 16.49 M 10.42 M 8.06 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity -1.49 M 44.42 M 123.82 M 94.68 M 42.80 M
    Common Stock 48,000.00 44,000.00 44,000.00 38,000.00 31,000.00
    Capital Surplus 330.74 M 323.01 M 312.08 M 210.76 M 132.64 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves 0.00 0.00 0.00 -1.58 M -2.23 M
    Unappropriated (Free) Reserves 0.00 0.00 0.00 0.00 0.00
    Retained Earnings -331.92 M -278.27 M -188.21 M -114.45 M -87.55 M
    Equity in Untaxed Reserves
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities 0.00 0.00 0.00 0.00 0.00
    Treasury Stock 357,000.00 357,000.00 89,000.00 89,000.00 89,000.00
    Total Liabilities & Shareholders Equity 26.63 M 81.06 M 140.31 M 105.10 M 50.86 M
    Common Shares Outstanding 47.65 M 43.67 M 43.46 M 37.78 M 31.32 M